The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils

被引:88
作者
Belus, Alexandra [1 ,2 ]
Piroddi, Nicoletta [1 ,2 ]
Scellini, Beatrice [1 ,2 ]
Tesi, Chiara [1 ,2 ]
Amati, Giulia D. [3 ]
Girolami, Francesca [4 ]
Yacoub, Magdi [5 ,6 ]
Cecchi, Franco [5 ,6 ]
Olivotto, Iacopo [6 ]
Poggesi, Corrado [1 ,2 ]
机构
[1] Univ Florence, Dept Physiol, I-50134 Florence, Italy
[2] Ctr Mol Med CIMMBA, Florence, Italy
[3] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[4] Careggi Univ Hosp, Dept Genet Diagnosis, Florence, Italy
[5] Univ Florence, Dept Med & Surg Crit Care, I-50134 Florence, Italy
[6] Univ Florence, Reg Referral Ctr Myocardial Dis, I-50134 Florence, Italy
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2008年 / 586卷 / 15期
关键词
D O I
10.1113/jphysiol.2008.155952
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The R403Q mutation in beta-myosin heavy chain was the first mutation to be identified as responsible for familial hypertrophic cardiomyopathy (FHC). In spite of extensive work on the functional sequelae of this mutation, the mechanism by which the mutant protein causes the disease has not been definitely identified. Here we directly compare contraction and relaxation mechanics of single myofibrils from left ventricular samples of one patient carrying the R403Q mutation to those from a healthy control heart. Tension generation and relaxation following sudden increase and decrease in [Ca2+] were much faster in the R403Q myofibrils with relaxation rates being the most affected parameters. The results show that the R403Q mutation leads to an apparent gain of protein function but a greater energetic cost of tension generation. Increased energy cost of tension generation may be central to the FHC disease process, help explain some unresolved clinical observations, and carry significant therapeutic implications.
引用
收藏
页码:3639 / 3644
页数:6
相关论文
共 23 条
  • [1] Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion
    Ashrafian, H
    Redwood, C
    Blair, E
    Watkins, H
    [J]. TRENDS IN GENETICS, 2003, 19 (05) : 263 - 268
  • [2] Belus A, 2007, BIOPHYS J, p181A
  • [4] Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy
    Crilley, JG
    Boehm, EA
    Blair, E
    Rajagopalan, B
    Blamire, AM
    Styles, P
    McKenna, WJ
    Östman-Smith, I
    Clarke, K
    Watkins, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) : 1776 - 1782
  • [5] SKELETAL-MUSCLE EXPRESSION AND ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
    CUDA, G
    FANANAPAZIR, L
    ZHU, WS
    SELLERS, JR
    EPSTEIN, ND
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) : 2861 - 2865
  • [6] Impact of temperature on cross-bridge cycling kinetics in rat myocardium
    de Tombe, Pieter P.
    Stienen, G. J. A.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2007, 584 (02): : 591 - 600
  • [7] Estimation of regional left ventricular wall stresses in intact canine hearts
    DeAnda, A
    Komeda, M
    Moon, MR
    Green, GR
    Bolger, AF
    Nikolic, SD
    Daughters, GT
    Miller, DC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05): : H1879 - H1885
  • [9] A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION
    GEISTERFERLOWRANCE, AAT
    KASS, S
    TANIGAWA, G
    VOSBERG, HP
    MCKENNA, W
    SEIDMAN, CE
    SEIDMAN, JG
    [J]. CELL, 1990, 62 (05) : 999 - 1006
  • [10] A mouse model of familial hypertrophic cardiomyopathy
    GeisterferLowrance, AAT
    Christe, M
    Conner, DA
    Ingwall, JS
    Schoen, FJ
    Seidman, CE
    Seidman, JG
    [J]. SCIENCE, 1996, 272 (5262) : 731 - 734